Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
AtriCure, Inc. (Nasdaq: ATRC), a medical device company and a leader in the development of technologies and solutions for the treatment of atrial fibrillation, or Afib, and systems for the exclusion of the left atrial appendage, will release its financial results for the second quarter of 2013 on Thursday, August 1, 2013.
Help employers find you! Check out all the jobs and post your resume.
AtriCure, Inc. (Nasdaq: ATRC), a medical device company and a leader in the development of technologies and solutions for the treatment of atrial fibrillation, or Afib, and systems for the exclusion of the left atrial appendage, will release its financial results for the second quarter of 2013 on Thursday, August 1, 2013.
Help employers find you! Check out all the jobs and post your resume.
